Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON20432Not yet recruiting
Randomised, single-blind trial of simethicone, sponsored by St. Antonius Ziekenhuis. Primary endpoint: Total mucosal visibility. Planned start Feb 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON20432.